Oklo Reports Friday Morning With Virtually No Revenue to Report. The Stock Trades 78% Below Its High.

Oklo reports Q2 earnings Friday with virtually no revenue as the pre-revenue advanced nuclear developer trades at $43, down 78% from its $193.84 high. The company's quarterly cash burn sits at $17.9 million against a $2.5 billion cash position, giving it years of runway before needing additional capital.

The focus shifts to operational milestones rather than financial metrics. Oklo's Groves test reactor in Texas reached first criticality less than a year after groundbreaking, marking a significant technical achievement for the micro-reactor developer. Investors will parse Friday's report for updates on reactor deployment timelines, regulatory approvals, and new customer commitments—the catalysts needed to justify the valuation.

The sharp decline from the $193 peak reflects a market no longer willing to pay for promises in the nuclear space. With essentially zero revenue to report, Oklo must demonstrate concrete progress converting its technology into commercial agreements. The company's substantial cash buffer removes near-term liquidity concerns, but customer wins and regulatory clearances will determine whether the stock has found a bottom or faces further compression.